LifeSci Capital Starts Apnimed Inc. (APMD) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts APMD Hot Sheet
Price: $18.63 +0.59%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Join SI Premium – FREE
LifeSci Capital initiates coverage on Apnimed Inc. (NASDAQ: APMD) with a Outperform rating and a price target of $50.00.
For an analyst ratings summary and ratings history on Apnimed Inc. click here. For more ratings news on Apnimed Inc. click here.
Shares of Apnimed Inc. closed at $25.63 yesterday.
You May Also Be Interested In
- UBS Starts TechnipFMC (FTI) at Buy
- Chardan Starts Inhibikase Therapeutics Inc (IKT) at Neutral
- Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
